EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT)

EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) was reported 485 times

EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHOTOTHERAPEUTIC KERATECTOMY 1 0.3333
1 LEFT-HANDEDNESS 1 0.2000
2 ACTIVITIES OF DAILY LIVING ASSESSMENT 1 0.0500
3 PROCEDURAL HEADACHE 16 0.0390
4 HEPATIC NEUROENDOCRINE TUMOUR 1 0.0270
5 MYASTHENIA GRAVIS CRISIS 25 0.0169
6 CATHETER SITE SCAR 1 0.0167
7 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 22 0.0153
8 OVERWORK 1 0.0128
9 PROCEDURAL DIZZINESS 4 0.0124
10 BLADDER TRABECULATION 1 0.0123
11 THYMECTOMY 1 0.0114
12 SPINAL SYNOVIAL CYST 1 0.0095
13 MYASTHENIA GRAVIS 68 0.0084
14 HEREDITARY MOTOR AND SENSORY NEUROPATHY 1 0.0076
15 DERMATOCHALASIS 1 0.0068
16 POST PROCEDURAL CONSTIPATION 1 0.0068
17 LUMBOSACRAL RADICULOPATHY 1 0.0062
18 INJECTION SITE EXFOLIATION 4 0.0060
19 ACUTE CARDIAC EVENT 1 0.0058
20 POST PROCEDURAL CELLULITIS 1 0.0055
21 PROCEDURAL NAUSEA 4 0.0050
22 PANCREATIC NEUROENDOCRINE TUMOUR 3 0.0047
23 TRANSURETHRAL PROSTATECTOMY 2 0.0040
24 ORTHOSIS USER 1 0.0036
25 BREAST CELLULITIS 1 0.0032
26 PROCEDURAL VOMITING 2 0.0031
27 INJECTION SITE HYPERTROPHY 1 0.0031
28 ECTROPION 1 0.0030
29 POST CONCUSSION SYNDROME 1 0.0029
30 SPINAL NERVE STIMULATOR IMPLANTATION 1 0.0029
31 BLOOD IMMUNOGLOBULIN G DECREASED 7 0.0028
32 THYMOMA 1 0.0028
33 LIVIDITY 1 0.0027
34 LAGOPHTHALMOS 1 0.0024
35 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
36 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 1 0.0023
37 THERAPY CHANGE 23 0.0023
38 MASTICATION DISORDER 7 0.0023
39 POST-TRAUMATIC PAIN 1 0.0022
40 SYMPTOM RECURRENCE 13 0.0022
41 EHLERS-DANLOS SYNDROME 1 0.0022
42 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
43 PROSTATE INFECTION 2 0.0021
44 BLADDER MASS 1 0.0020
45 PLASMAPHERESIS 1 0.0019
46 DEVICE USE CONFUSION 1 0.0019
47 NAIL RIDGING 1 0.0019
48 UTERINE INFECTION 1 0.0019
49 VITH NERVE PARALYSIS 2 0.0018
50 DYSPNOEA AT REST 5 0.0017
51 CELLULITIS ORBITAL 1 0.0017
52 LARGE INTESTINE INFECTION 2 0.0016
53 PROSTATE CANCER RECURRENT 1 0.0016
54 SITTING DISABILITY 1 0.0016
55 INTERVERTEBRAL DISC OPERATION 2 0.0016
56 BACILLUS INFECTION 1 0.0016
57 POSTOPERATIVE ABSCESS 1 0.0015
58 HEAT ILLNESS 1 0.0015
59 EYELID PTOSIS 15 0.0015
60 MICTURITION FREQUENCY DECREASED 1 0.0013
61 PERFORATED ULCER 1 0.0013
62 MUSCLE DISCOMFORT 1 0.0013
63 INFUSION SITE PRURITUS 4 0.0013
64 HEAT EXHAUSTION 1 0.0012
65 EXCESSIVE GRANULATION TISSUE 1 0.0012
66 CARTILAGE ATROPHY 1 0.0012
67 RENAL ABSCESS 1 0.0012
68 PYLORIC STENOSIS 1 0.0012
69 INJECTION SITE COLDNESS 1 0.0012
70 COLONIC ABSCESS 1 0.0012
71 OPHTHALMIC HERPES ZOSTER 2 0.0011
72 INJECTION SITE DRYNESS 1 0.0011
73 TRAUMATIC INTRACRANIAL HAEMORRHAGE 1 0.0011
74 WRIST SURGERY 1 0.0011
75 SOLAR LENTIGO 1 0.0011
76 FACE INJURY 4 0.0011
77 MECHANICAL VENTILATION 2 0.0011
78 DEVICE RELATED THROMBOSIS 1 0.0010
79 METASTASES TO SKIN 1 0.0010
80 CONSCIOUSNESS FLUCTUATING 1 0.0010
81 INFUSION SITE BRUISING 2 0.0009
82 ESSENTIAL TREMOR 1 0.0009
83 BLOOD FIBRINOGEN DECREASED 1 0.0009
84 WALKING AID USER 5 0.0008
85 MIGRAINE WITH AURA 2 0.0007
86 TONGUE DRY 1 0.0007
87 SIALOADENITIS 1 0.0007
88 INFUSION SITE RASH 1 0.0007
89 IMMUNOGLOBULINS DECREASED 1 0.0007
90 DISCHARGE 1 0.0007
91 SUDDEN ONSET OF SLEEP 1 0.0007
92 CHOKING 14 0.0007
93 JOINT INSTABILITY 1 0.0007
94 THERAPEUTIC PROCEDURE 1 0.0007
95 MUSCLE FATIGUE 3 0.0007
96 NEUROENDOCRINE TUMOUR 1 0.0007
97 INTENSIVE CARE 1 0.0007
98 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
99 ANKLE OPERATION 1 0.0007
100 MENTAL FATIGUE 1 0.0007
101 ORAL MUCOSAL ERUPTION 1 0.0007
102 SKIN ABRASION 3 0.0006
103 COSTOCHONDRITIS 1 0.0006
104 INJECTION SITE INFECTION 2 0.0006
105 INJECTION RELATED REACTION 1 0.0006
106 TREATMENT DELAYED 1 0.0006
107 ROTATOR CUFF REPAIR 1 0.0006
108 IMMUNOSUPPRESSION 5 0.0006
109 TERMINAL INSOMNIA 1 0.0006
110 INDURATION 1 0.0006
111 AORTIC VALVE STENOSIS 1 0.0006
112 CARDIAC ABLATION 1 0.0006
113 PNEUMONIA KLEBSIELLA 1 0.0005
114 BODY TEMPERATURE ABNORMAL 1 0.0005
115 DIPLOPIA 14 0.0005
116 TUNNEL VISION 1 0.0005
117 PERONEAL NERVE PALSY 3 0.0005
118 INSURANCE ISSUE 8 0.0005
119 MOTION SICKNESS 1 0.0005
120 REHABILITATION THERAPY 2 0.0005
121 ABDOMINAL WALL HAEMATOMA 1 0.0005
122 COLOSTOMY 1 0.0005
123 NAIL DISCOLOURATION 2 0.0005
124 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
125 TEMPERATURE INTOLERANCE 5 0.0005
126 POOR VENOUS ACCESS 5 0.0005
127 CHEST INJURY 1 0.0005
128 WALKING DISABILITY 1 0.0005
129 LUNG ABSCESS 1 0.0005
130 DEVICE CONNECTION ISSUE 1 0.0005
131 EYE CONTUSION 1 0.0005
132 FACIAL PARALYSIS 4 0.0005
133 CATHETER SITE ERYTHEMA 1 0.0005
134 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
135 GASTRIC BYPASS 1 0.0005
136 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
137 ABDOMINAL ABSCESS 2 0.0005
138 DYSARTHRIA 17 0.0005
139 PARESIS 1 0.0004
140 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
141 EYELID DISORDER 1 0.0004
142 INJECTION SITE RASH 13 0.0004
143 PUSTULE 1 0.0004
144 SINUS OPERATION 1 0.0004
145 URINARY HESITATION 1 0.0004
146 HAEMATOLOGICAL INFECTION 1 0.0004
147 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
148 INJECTION SITE INFLAMMATION 2 0.0004
149 ABDOMINAL INFECTION 1 0.0004
150 AORTIC ARTERIOSCLEROSIS 1 0.0004
151 CATHETER SITE PAIN 1 0.0004
152 HEPATITIS TOXIC 1 0.0004
153 SENSITIVITY TO WEATHER CHANGE 2 0.0004
154 EXFOLIATIVE RASH 1 0.0004
155 ANAESTHETIC COMPLICATION 1 0.0004
156 HIP SURGERY 2 0.0004
157 CLUMSINESS 1 0.0004
158 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
159 JOINT LOCK 1 0.0004
160 INJECTION SITE SCAR 1 0.0004
161 FIBULA FRACTURE 1 0.0003
162 STRABISMUS 1 0.0003
163 LOSS OF EMPLOYMENT 1 0.0003
164 INJECTION SITE VESICLES 2 0.0003
165 EMERGENCY CARE 1 0.0003
166 PROSTATITIS 1 0.0003
167 DIABETIC FOOT 1 0.0003
168 MUSCULAR WEAKNESS 37 0.0003
169 TALIPES 1 0.0003
170 INJECTION SITE DISCOLOURATION 4 0.0003
171 INJECTION SITE HYPERSENSITIVITY 1 0.0003
172 BRAIN FOG 5 0.0003
173 SQUAMOUS CELL CARCINOMA 3 0.0003
174 BLEPHAROSPASM 2 0.0003
175 FOREIGN BODY IN THROAT 1 0.0003
176 MUSCLE ATROPHY 4 0.0003
177 POLYMYALGIA RHEUMATICA 1 0.0003
178 SWOLLEN JOINT COUNT INCREASED 1 0.0003
179 THROMBOSIS IN DEVICE 1 0.0003
180 BEDRIDDEN 4 0.0003
181 LYME DISEASE 1 0.0003
182 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
183 REGURGITATION 1 0.0003
184 LYMPHOEDEMA 2 0.0003
185 GLOSSITIS 1 0.0003
186 IMPAIRED QUALITY OF LIFE 4 0.0003
187 SCLERODERMA 1 0.0003
188 IMMUNODEFICIENCY 4 0.0003
189 CHEMOTHERAPY 1 0.0003
190 PARANASAL SINUS DISCOMFORT 1 0.0003
191 APHTHOUS ULCER 2 0.0003
192 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
193 MUSCLE RUPTURE 1 0.0003
194 PROCEDURAL HAEMORRHAGE 1 0.0003
195 OESOPHAGEAL PAIN 1 0.0003
196 CEREBRAL ATROPHY 1 0.0003
197 STENT PLACEMENT 2 0.0002
198 HOMICIDAL IDEATION 1 0.0002
199 SPINAL FUSION SURGERY 1 0.0002
200 SPINAL OPERATION 3 0.0002
201 LEG AMPUTATION 1 0.0002
202 INJECTION SITE PRURITUS 16 0.0002
203 ONYCHOMADESIS 1 0.0002
204 TONGUE DISCOMFORT 1 0.0002
205 INFUSION SITE PAIN 3 0.0002
206 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
207 SYRINGE ISSUE 4 0.0002
208 PULMONARY CONGESTION 3 0.0002
209 MENINGITIS ASEPTIC 1 0.0002
210 SUSPECTED OFF LABEL USE 1 0.0002
211 INJECTION SITE PAPULE 1 0.0002
212 LUMBAR VERTEBRAL FRACTURE 1 0.0002
213 INCREASED TENDENCY TO BRUISE 2 0.0002
214 MUSCLE TWITCHING 5 0.0002
215 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
216 TIBIA FRACTURE 1 0.0002
217 INJECTION SITE BRUISING 17 0.0002
218 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
219 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
220 AUTOIMMUNE DISORDER 2 0.0002
221 KNEE OPERATION 2 0.0002
222 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
223 INJECTION SITE ERYTHEMA 25 0.0002
224 DYSPHAGIA 19 0.0002
225 VEIN DISORDER 1 0.0002
226 TOXIC ENCEPHALOPATHY 1 0.0002
227 MOTOR DYSFUNCTION 2 0.0002
228 SLUGGISHNESS 2 0.0002
229 PETIT MAL EPILEPSY 1 0.0002
230 ENDOCARDITIS 1 0.0002
231 LIMB DISCOMFORT 6 0.0002
232 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
233 THERAPY PARTIAL RESPONDER 3 0.0002
234 CYSTITIS 6 0.0002
235 NYSTAGMUS 1 0.0002
236 THROAT TIGHTNESS 5 0.0002
237 CHEILITIS 1 0.0002
238 BACK INJURY 2 0.0002
239 HYDROCEPHALUS 1 0.0002
240 ASTHENOPIA 1 0.0002
241 THERAPY INTERRUPTED 13 0.0002
242 INJECTION SITE INJURY 1 0.0002
243 PROCEDURAL PAIN 5 0.0002
244 PRODUCT LEAKAGE 1 0.0002
245 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
246 COLECTOMY 1 0.0002
247 PERIORBITAL SWELLING 1 0.0002
248 MICTURITION URGENCY 2 0.0002
249 INJECTION SITE REACTION 12 0.0002
250 NEEDLE ISSUE 5 0.0002
251 PRODUCT LABEL CONFUSION 1 0.0002
252 DYSSTASIA 5 0.0002
253 COLD SWEAT 3 0.0002
254 MENISCUS INJURY 1 0.0002
255 INFUSION SITE EXTRAVASATION 1 0.0002
256 SWELLING OF EYELID 1 0.0002
257 PHOTOPSIA 1 0.0002
258 HEAD INJURY 5 0.0002
259 HERNIA 3 0.0002
260 KIDNEY INFECTION 3 0.0002
261 STAPHYLOCOCCAL INFECTION 5 0.0002
262 PRODUCT FORMULATION ISSUE 1 0.0002
263 BALANCE DISORDER 13 0.0002
264 GAIT INABILITY 5 0.0001
265 QUALITY OF LIFE DECREASED 2 0.0001
266 POSTOPERATIVE WOUND INFECTION 1 0.0001
267 PRODUCT LABEL ISSUE 1 0.0001
268 LIMB INJURY 4 0.0001
269 ECCHYMOSIS 1 0.0001
270 DIVERTICULITIS 4 0.0001
271 COORDINATION ABNORMAL 2 0.0001
272 APHONIA 2 0.0001
273 JOINT INJURY 3 0.0001
274 FEAR OF INJECTION 1 0.0001
275 MOBILITY DECREASED 10 0.0001
276 TONGUE DISORDER 1 0.0001
277 ORAL DISORDER 1 0.0001
278 SENSITIVE SKIN 1 0.0001
279 URINARY INCONTINENCE 4 0.0001
280 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
281 AORTIC ANEURYSM 1 0.0001
282 HIP ARTHROPLASTY 2 0.0001
283 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
284 DEVICE RELATED INFECTION 2 0.0001
285 CONCUSSION 1 0.0001
286 BASAL CELL CARCINOMA 2 0.0001
287 MULTIPLE ALLERGIES 1 0.0001
288 HALLUCINATION, AUDITORY 2 0.0001
289 MUSCLE DISORDER 1 0.0001
290 MUSCLE TIGHTNESS 2 0.0001
291 URINARY TRACT INFECTION 21 0.0001
292 POST PROCEDURAL INFECTION 1 0.0001
293 DECUBITUS ULCER 1 0.0001
294 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
295 PHOTOSENSITIVITY REACTION 2 0.0001
296 SPINAL COMPRESSION FRACTURE 1 0.0001
297 DEVICE DIFFICULT TO USE 8 0.0001
298 HEMIPLEGIA 1 0.0001
299 SENSATION OF FOREIGN BODY 1 0.0001
300 INFUSION SITE ERYTHEMA 1 0.0001
301 INJECTION SITE SWELLING 9 0.0001
302 UNRESPONSIVE TO STIMULI 3 0.0001
303 MUSCULOSKELETAL DISCOMFORT 2 0.0001
304 BLOOD MAGNESIUM DECREASED 1 0.0001
305 NEUROPATHY PERIPHERAL 11 0.0001
306 HYSTERECTOMY 1 0.0001
307 SEPTIC SHOCK 5 0.0001
308 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
309 URINE OUTPUT DECREASED 1 0.0001
310 SPINAL OSTEOARTHRITIS 1 0.0001
311 GRIP STRENGTH DECREASED 1 0.0001
312 PRODUCT COMMUNICATION ISSUE 1 0.0001
313 FACIAL PAIN 1 0.0001
314 ANAL INCONTINENCE 1 0.0001
315 FALL 37 0.0001
316 GASTROENTERITIS VIRAL 2 0.0001
317 GASTROINTESTINAL CARCINOMA 1 0.0001
318 NEPHROLITHIASIS 5 0.0001
319 RETINAL DETACHMENT 1 0.0001
320 DYSURIA 4 0.0001
321 UROSEPSIS 1 0.0001
322 NERVE COMPRESSION 1 0.0001
323 IRON DEFICIENCY ANAEMIA 1 0.0001
324 NEPHROPATHY 1 0.0001
325 OXYGEN SATURATION DECREASED 6 0.0001
326 ASTHENIA 40 0.0001
327 PHOTOPHOBIA 2 0.0001
328 DYSPNOEA EXERTIONAL 4 0.0001
329 PRODUCT PACKAGING ISSUE 1 0.0001
330 FEELING JITTERY 2 0.0001
331 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
332 PHARYNGEAL SWELLING 1 0.0001
333 VITREOUS FLOATERS 1 0.0001
334 HOSPICE CARE 1 0.0001
335 DISABILITY 2 0.0001
336 LIGAMENT SPRAIN 1 0.0001
337 SPINAL FRACTURE 2 0.0001
338 HYPOTHERMIA 1 0.0001
339 THERAPY CESSATION 5 0.0001
340 INJECTION SITE WARMTH 2 0.0001
341 VENTRICULAR EXTRASYSTOLES 1 0.0001
342 SWOLLEN TONGUE 3 0.0001
343 WEIGHT FLUCTUATION 1 0.0001
344 SPEECH DISORDER 5 0.0001
345 INJECTION SITE DISCOMFORT 1 0.0001
346 SCRATCH 1 0.0001
347 INCONTINENCE 1 0.0001
348 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
349 IMPAIRED WORK ABILITY 2 0.0001
350 BIPOLAR DISORDER 1 0.0001
351 SKIN LACERATION 1 0.0001
352 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
353 ASPIRATION 1 0.0001
354 EYE DISORDER 3 0.0001
355 GASTROINTESTINAL PAIN 1 0.0001
356 TOOTH FRACTURE 1 0.0001
357 BLOOD CALCIUM DECREASED 1 0.0001
358 EYE PAIN 5 0.0001
359 HEART RATE IRREGULAR 2 0.0001
360 NEOPLASM 1 0.0001
361 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
362 FATIGUE 67 0.0001
363 RASH MACULAR 3 0.0001
364 DYSPHONIA 5 0.0001
365 SPINAL PAIN 1 0.0001
366 LYMPHADENOPATHY 3 0.0001
367 CATARACT 5 0.0001
368 MIGRAINE 8 0.0001
369 FIBROMYALGIA 2 0.0001
370 PRESYNCOPE 2 0.0001
371 NASOPHARYNGITIS 15 0.0001
372 INJECTION SITE EXTRAVASATION 1 0.0001
373 TENDON RUPTURE 1 0.0001
374 TOOTH EXTRACTION 1 0.0001
375 HYPOAESTHESIA 12 0.0001
376 POISONING 1 0.0001
377 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
378 CONDITION AGGRAVATED 24 0.0001
379 INJECTION SITE IRRITATION 1 0.0001
380 BLOOD PRESSURE INCREASED 12 0.0001
381 INJECTION SITE PAIN 24 0.0001
382 DEVICE ISSUE 7 0.0001
383 INJECTION SITE INDURATION 1 0.0001
384 MUSCULOSKELETAL PAIN 4 0.0001
385 JOINT STIFFNESS 2 0.0001
386 IMMUNE SYSTEM DISORDER 1 0.0001
387 DYSMENORRHOEA 1 0.0001
388 EAR INFECTION 2 0.0001
389 TACHYPNOEA 1 0.0001
390 IMPAIRED GASTRIC EMPTYING 1 0.0001
391 PERIPHERAL COLDNESS 1 0.0001
392 RESPIRATORY DISTRESS 2 0.0001
393 ORAL DISCOMFORT 1 0.0001
394 INFLUENZA 8 0.0001
395 SEPSIS 8 0.0001
396 NECK PAIN 4 0.0001
397 MASS 1 0.0001
398 BURNING SENSATION 5 0.0001
399 DEVICE OCCLUSION 1 0.0001
400 SKIN REACTION 1 0.0001
401 INTENTIONAL DOSE OMISSION 2 0.0001
402 HERPES ZOSTER 4 0.0001
403 PARAESTHESIA ORAL 1 0.0001
404 DEVICE LEAKAGE 3 0.0001
405 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
406 MENTAL DISORDER 3 0.0001
407 INJECTION SITE HAEMATOMA 1 0.0001
408 GASTROENTERITIS 1 0.0001
409 SINUSITIS 7 0.0001
410 SURGERY 4 0.0001
411 NASAL CONGESTION 4 0.0001
412 PULMONARY MASS 1 0.0001
413 THERAPY NON-RESPONDER 3 0.0001
414 BLOOD POTASSIUM DECREASED 2 0.0001
415 HYPOAESTHESIA ORAL 1 0.0001
416 VERTIGO 4 0.0001
417 THYROID DISORDER 1 0.0001
418 ANKLE FRACTURE 1 0.0001
419 COGNITIVE DISORDER 3 0.0001
420 NERVOUS SYSTEM DISORDER 2 0.0001
421 ULCER 1 0.0001
422 PRODUCTIVE COUGH 3 0.0001
423 RASH ERYTHEMATOUS 3 0.0001
424 SCIATICA 1 0.0001
425 ABSCESS 1 0.0001
426 CONTUSION 6 0.0001
427 HIP FRACTURE 2 0.0001
428 THROMBOSIS 5 0.0001
429 BLOOD POTASSIUM INCREASED 1 0.0001
430 BACK DISORDER 1 0.0001
431 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
432 METASTASES TO BONE 1 0.0001
433 IMPAIRED HEALING 2 0.0001
434 INFUSION RELATED REACTION 4 0.0001
435 BLOOD PRESSURE DECREASED 4 0.0001
436 FUNGAL INFECTION 2 0.0001
437 SKIN DISORDER 2 0.0001
438 CHILLS 7 0.0001
439 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
440 CANDIDA INFECTION 1 0.0001
441 HEMIPARESIS 1 0.0001
442 VISION BLURRED 8 0.0001
443 HEART RATE DECREASED 2 0.0001
444 LYMPHOCYTE COUNT DECREASED 1 0.0001
445 DRUG ERUPTION 1 0.0001
446 THIRST 1 0.0001
447 BRONCHITIS 4 0.0001
448 HEPATIC CIRRHOSIS 1 0.0001
449 BLOOD SODIUM DECREASED 1 0.0001
450 MYALGIA 9 0.0001
451 FRACTURE 1 0.0001
452 BLOOD URINE PRESENT 1 0.0001
453 MUSCULOSKELETAL DISORDER 1 0.0001
454 PULMONARY FIBROSIS 1 0.0001
455 HOSPITALISATION 8 0.0001
456 LOWER LIMB FRACTURE 1 0.0001
457 PERIPHERAL SWELLING 8 0.0001
458 GLAUCOMA 1 0.0001
459 EAR PAIN 1 0.0001
460 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
461 HAEMORRHOIDS 1 0.0001
462 SKIN FISSURES 1 0.0001
463 PARAESTHESIA 8 0.0001
464 CARDIAC FAILURE 4 0.0000
465 SOMNOLENCE 10 0.0000
466 PRODUCT ADMINISTRATION ERROR 1 0.0000
467 ILL-DEFINED DISORDER 3 0.0000
468 FEEDING DISORDER 1 0.0000
469 TASTE DISORDER 1 0.0000
470 BODY TEMPERATURE INCREASED 1 0.0000
471 CHEST DISCOMFORT 5 0.0000
472 LUNG NEOPLASM MALIGNANT 2 0.0000
473 RIB FRACTURE 1 0.0000
474 INFLUENZA LIKE ILLNESS 4 0.0000
475 TOOTH LOSS 1 0.0000
476 TREMOR 8 0.0000
477 POLLAKIURIA 2 0.0000
478 KNEE ARTHROPLASTY 1 0.0000
479 HALLUCINATION, VISUAL 1 0.0000
480 BACK PAIN 11 0.0000
481 GAIT DISTURBANCE 9 0.0000
482 LIVER FUNCTION TEST INCREASED 1 0.0000
483 POOR QUALITY SLEEP 1 0.0000
484 SKIN CANCER 1 0.0000
485 FAECES DISCOLOURED 1 0.0000
486 COVID-19 8 0.0000
487 HEPATOTOXICITY 1 0.0000
488 GLOSSODYNIA 1 0.0000
489 ADVERSE DRUG REACTION 4 0.0000
490 MUSCLE SPASMS 8 0.0000
491 SKIN DISCOLOURATION 2 0.0000
492 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
493 RENAL DISORDER 2 0.0000
494 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
495 SWELLING 4 0.0000
496 BLOOD PRESSURE FLUCTUATION 1 0.0000
497 BLOOD GLUCOSE DECREASED 2 0.0000
498 HEPATIC CANCER 1 0.0000
499 LOCALISED INFECTION 1 0.0000
500 MENTAL IMPAIRMENT 1 0.0000
501 NEURALGIA 1 0.0000
502 ATRIAL FIBRILLATION 4 0.0000
503 INJECTION SITE URTICARIA 1 0.0000
504 HEART RATE INCREASED 4 0.0000
505 PNEUMONIA ASPIRATION 1 0.0000
506 SYNCOPE 4 0.0000
507 CELLULITIS 2 0.0000
508 DIABETES MELLITUS 3 0.0000
509 LOSS OF CONSCIOUSNESS 5 0.0000
510 ILLNESS 4 0.0000
511 SKIN ULCER 1 0.0000
512 ARTHRALGIA 16 0.0000
513 ABDOMINAL DISTENSION 4 0.0000
514 HEADACHE 24 0.0000
515 ECZEMA 2 0.0000
516 DEPRESSED MOOD 2 0.0000
517 FEELING ABNORMAL 9 0.0000
518 INSOMNIA 10 0.0000
519 PRODUCT DOSE OMISSION ISSUE 11 0.0000
520 PAIN IN EXTREMITY 11 0.0000
521 DYSPNOEA 21 0.0000
522 RASH PRURITIC 2 0.0000
523 PALLOR 1 0.0000
524 MOOD ALTERED 1 0.0000
525 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
526 HAEMATOCHEZIA 2 0.0000
527 MENTAL STATUS CHANGES 1 0.0000
528 ARTHROPATHY 2 0.0000
529 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
530 DEMENTIA 1 0.0000
531 SKIN EXFOLIATION 3 0.0000
532 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
533 HYPERSOMNIA 1 0.0000
534 LETHARGY 2 0.0000
535 INFECTION 5 0.0000
536 LIVER FUNCTION TEST ABNORMAL 1 0.0000
537 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
538 ERYTHEMA 7 0.0000
539 PNEUMONIA 11 0.0000
540 ACUTE MYOCARDIAL INFARCTION 1 0.0000
541 RESPIRATORY DISORDER 1 0.0000
542 LACRIMATION INCREASED 1 0.0000
543 FEELING HOT 2 0.0000
544 OROPHARYNGEAL PAIN 3 0.0000
545 DIZZINESS 16 0.0000
546 PULMONARY EMBOLISM 3 0.0000
547 DRUG INTERACTION 5 0.0000
548 MOVEMENT DISORDER 1 0.0000
549 HYPERHIDROSIS 4 0.0000
550 NIGHT SWEATS 1 0.0000
551 RHINORRHOEA 2 0.0000
552 CONFUSIONAL STATE 5 0.0000
553 VIRAL INFECTION 1 0.0000
554 URINARY RETENTION 1 0.0000
555 RASH 13 0.0000
556 EYE PRURITUS 1 0.0000
557 TYPE 2 DIABETES MELLITUS 1 0.0000
558 NIGHTMARE 1 0.0000
559 DRUG INEFFECTIVE 38 0.0000
560 DELIRIUM 1 0.0000
561 DEVICE USE ERROR 1 0.0000
562 COUGH 8 0.0000
563 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
564 PANIC ATTACK 1 0.0000
565 RESTLESSNESS 1 0.0000
566 INJECTION SITE MASS 1 0.0000
567 CHEST PAIN 5 0.0000
568 EYE SWELLING 1 0.0000
569 INTESTINAL OBSTRUCTION 1 0.0000
570 COLITIS 1 0.0000
571 DEPRESSION 6 0.0000
572 PLASMA CELL MYELOMA 1 0.0000
573 ARTHRITIS 2 0.0000
574 HYPOTENSION 5 0.0000
575 CARDIAC FAILURE CONGESTIVE 2 0.0000
576 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
577 DRY MOUTH 2 0.0000
578 DEVICE BREAKAGE 1 0.0000
579 DYSKINESIA 1 0.0000
580 BLINDNESS 1 0.0000
581 ROAD TRAFFIC ACCIDENT 1 0.0000
582 RENAL IMPAIRMENT 2 0.0000
583 HYPERTENSION 5 0.0000
584 RECTAL HAEMORRHAGE 1 0.0000
585 PAIN 14 0.0000
586 ANGIOEDEMA 1 0.0000
587 PULMONARY OEDEMA 1 0.0000
588 THROAT IRRITATION 1 0.0000
589 MEMORY IMPAIRMENT 3 0.0000
590 SKIN IRRITATION 1 0.0000
591 TINNITUS 1 0.0000
592 DECREASED APPETITE 5 0.0000
593 NAUSEA 17 0.0000
594 OCULAR HYPERAEMIA 1 0.0000
595 MULTIPLE SCLEROSIS 1 0.0000
596 DEATH 18 0.0000
597 DRUG INTOLERANCE 2 0.0000
598 LEUKOPENIA 1 0.0000
599 AGGRESSION 1 0.0000
600 HAEMORRHAGE 2 0.0000
601 DERMATITIS ATOPIC 1 0.0000
602 DISTURBANCE IN ATTENTION 1 0.0000
603 MALAISE 8 0.0000
604 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
605 WEIGHT DECREASED 5 0.0000
606 URTICARIA 3 0.0000
607 WEIGHT INCREASED 4 0.0000
608 BLISTER 1 0.0000
609 RHEUMATOID ARTHRITIS 2 0.0000
610 EYE IRRITATION 1 0.0000
611 PYREXIA 6 0.0000
612 SEIZURE 2 0.0000
613 MYOCARDIAL INFARCTION 3 0.0000
614 PALPITATIONS 2 0.0000
615 VOMITING 8 0.0000
616 WHEEZING 1 0.0000
617 DISCOMFORT 1 0.0000
618 VISUAL IMPAIRMENT 2 0.0000
619 EXPOSURE DURING PREGNANCY 1 0.0000
620 ANAEMIA 3 0.0000
621 PRURITUS 6 0.0000
622 DEEP VEIN THROMBOSIS 1 0.0000
623 AMNESIA 1 0.0000
624 SWELLING FACE 1 0.0000
625 DEHYDRATION 2 0.0000
626 NEOPLASM MALIGNANT 1 0.0000
627 HEPATIC ENZYME INCREASED 1 0.0000
628 ABDOMINAL PAIN UPPER 3 0.0000
629 DEVICE MALFUNCTION 1 0.0000
630 INJURY 1 0.0000
631 SLEEP DISORDER 1 0.0000
632 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
633 ANXIETY 4 0.0000
634 DIARRHOEA 9 0.0000
635 OFF LABEL USE 12 0.0000
636 AGITATION 1 0.0000
637 DYSGEUSIA 1 0.0000
638 UNEVALUABLE EVENT 1 0.0000
639 ACNE 1 0.0000
640 CHRONIC KIDNEY DISEASE 1 0.0000
641 INJECTION SITE HAEMORRHAGE 1 0.0000
642 PROSTATE CANCER 1 0.0000
643 CARDIAC ARREST 1 0.0000
644 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
645 ABDOMINAL DISCOMFORT 2 0.0000
646 INTENTIONAL PRODUCT MISUSE 1 0.0000
647 MUSCULOSKELETAL STIFFNESS 1 0.0000
648 DRUG WITHDRAWAL SYNDROME 1 0.0000
649 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
650 GASTROINTESTINAL DISORDER 1 0.0000
651 NO ADVERSE EVENT 2 0.0000
652 ADVERSE EVENT 1 0.0000
653 HYPERSENSITIVITY 2 0.0000
654 CARDIAC DISORDER 1 0.0000
655 PRODUCT USE ISSUE 2 0.0000
656 ALOPECIA 2 0.0000
657 DYSPEPSIA 1 0.0000
658 FLUSHING 1 0.0000
659 HAEMOGLOBIN DECREASED 1 0.0000
660 ASTHMA 1 0.0000
661 INCORRECT DOSE ADMINISTERED 2 0.0000
662 DISEASE PROGRESSION 1 0.0000
663 JOINT SWELLING 1 0.0000
664 OEDEMA PERIPHERAL 1 0.0000
665 RENAL FAILURE 1 0.0000
666 DRY SKIN 1 0.0000
667 DRUG DEPENDENCE 1 0.0000
668 CEREBROVASCULAR ACCIDENT 1 0.0000
669 ABDOMINAL PAIN 1 0.0000